Sentences with phrase «ovarian cancer at»

My mom died of ovarian cancer at age 68, and I never got to take a trip with her.

Soon after her husband's sudden death from a heart attack two years ago, Jill's daughter Rachel was diagnosed with ovarian cancer at the very young age of 21.

The following ailments found in two family members may be a sign of hereditary cancer: • Breast cancer (one before age 50) • Ovarian cancer at any age • One with breast cancer and one with ovarian cancer

Researchers reported in May that one such drug kept ovarian cancer at bay nearly twice as long as a placebo.

«New screening strategy may catch ovarian cancer at early stages.»

Our ambition is that this approach will be capable of detecting ovarian cancer at an earlier stage and save lives.

Doctors have had little success diagnosing ovarian cancer at its earliest, most treatable states or identifying women at risk for the disease, for example.

Researchers at the Georgia Institute of Technology collected blood from 44 women diagnosed with ovarian cancer at various stages, along with that from 50 healthy controls.

Bordner's primary charity, the National Ovarian Cancer Coalition, is a cause close to her heart: in 2009, Danah's best friend Erika passed away from ovarian cancer at age 29.

Not exact matches

Juno also has a few other compounds in early stages of development aimed at treating NHL, pediatric ALL, multiple myeloma, ovarian & breast cancer, AML, lung cancer, and more.

At this late stage, ovarian cancer is difficult to treat and is often fatal.

Several observational studies have looked at the link between increased consumption of onions and a reduced risk of certain types of cancers, including stomach, breast, colon, prostate and ovarian.

Truex's longtime girlfriend, Sherry Pollex, is battling a recurrence of ovarian cancer, crew chief Cole Pearn's close friend died unexpectedly from a bacterial infection in August, and last month crew member James Watson, 55, died after a go - kart team outing on the race weekend at Kansas Speedway.

Kelly and accomplished master baker and cake decorator Buddy Valastro, from TLC's «Cake Boss,» recently joined forces at a fun event to bake lavishly decorated cakes in support of The Ovarian Cancer Research...

They are also at greater risk for rare but serious conditions such as severe lower respiratory infections, leukemia, necrotizing enterocolitis, and sudden infant death syndrome (SIDS).5 Breastfeeding is also good for moms, lowering the risk for breast cancer, ovarian cancer, type 2 diabetes, and cardiovascular disease.6, 7

Children and mothers who do not breastfeed are at greater risk for many conditions including acute and chronic illness for children, and breast and ovarian cancer for mothers.

lower risk of ovarian cancer, as does having used birth control at any point in your life.

Our friends at Bright Pink have made it their mission to spread knowledge about breast and ovarian cancer, empowering women to be proactive about their health.

New York state Assemblyman Frank Skartados died at St. Luke's Cornwall Hospital in Newburgh after a brief battle with pancreatic cancer, while Newburgh Mayor Judy Kennedy died from ovarian cancer after a diagnosis two years ago.

There was a service for Newburgh Mayor Judy Kennedy, who died at age 73 from ovarian cancer.

Also at 11 a.m., Brooklyn BP Eric Adams and NYC Councilman Rafael Espinal, who lost his mother to ovarian cancer, hold event to show support for Tell Every Amazing Lady About Ovarian Cancer (T.E.A.L.) and announce that Brooklyn Borough Hall will be lit up in the color teal from Sept. 6th through Sept. 9th, Brooklyn Borough Hall Rotunda, 209 Joralemon St., Brovarian cancer, hold event to show support for Tell Every Amazing Lady About Ovarian Cancer (T.E.A.L.) and announce that Brooklyn Borough Hall will be lit up in the color teal from Sept. 6th through Sept. 9th, Brooklyn Borough Hall Rotunda, 209 Joralemon St., Brocancer, hold event to show support for Tell Every Amazing Lady About Ovarian Cancer (T.E.A.L.) and announce that Brooklyn Borough Hall will be lit up in the color teal from Sept. 6th through Sept. 9th, Brooklyn Borough Hall Rotunda, 209 Joralemon St., BrOvarian Cancer (T.E.A.L.) and announce that Brooklyn Borough Hall will be lit up in the color teal from Sept. 6th through Sept. 9th, Brooklyn Borough Hall Rotunda, 209 Joralemon St., BroCancer (T.E.A.L.) and announce that Brooklyn Borough Hall will be lit up in the color teal from Sept. 6th through Sept. 9th, Brooklyn Borough Hall Rotunda, 209 Joralemon St., Brooklyn.

«Nonetheless, the proof of concept studies we have obtained thus far are extremely encouraging, and we are confident that with proper support and efforts we could translate our findings into experimental therapeutics for a variety of solid tumors that are driven by EphA2 overexpression, including breast, lung, prostate, pancreatic, and ovarian cancers,» said Pellecchia, who serves as the founding director of the Center for Molecular and Translational Medicine at UCR.

Her work in protein research at Hunter and her grandmother's recent diagnosis of ovarian cancer sparked an interest in cancer biology and immunology, but Rezende is eager to sample other fields.

The 54 - year - old neuropsychologist underwent her psilocybin session at UCLA last May, shortly after her ovarian cancer had come roaring back in spite of two rounds of intensive chemotherapy.

«Our discovery of these mutations is a first step in developing a genetics - based system for classifying endometriosis so that clinicians can sort out which forms of the disorder may need more aggressive treatment and which may not,» says Ie - Ming Shih, M.D., Ph.D., the Richard W. TeLinde Distinguished Professor in the Department of Gynecology & Obstetrics at the Johns Hopkins University School of Medicine and co-director of the Breast and Ovarian Cancer Program at the Johns Hopkins Kimmel Cancer Center.

Working in cell cultures and mice, researchers at Johns Hopkins have found that an experimental drug called fostamatinib combined with the chemotherapy drug paclitaxel may overcome ovarian cancer cells» resistance to paclitaxel.

Scientists at Lawson Health Research Institute have uncovered an important new target for ovarian cancer therapy.

Three trials are now open for OMP - 54F28 (FZD8 - Fc) in combinations with standard therapy for pancreatic, ovarian and liver cancers, being offered at the CU Cancer Center and elsewhere.

«Because there is currently no reliable screening available for ovarian cancer, most cases are diagnosed at advanced stages,» said the study's author, Bo (Bonnie) Qin, PhD, a postdoctoral associate at Rutgers Cancer Institute of New Jcancer, most cases are diagnosed at advanced stages,» said the study's author, Bo (Bonnie) Qin, PhD, a postdoctoral associate at Rutgers Cancer Institute of New JCancer Institute of New Jersey.

The National Cancer Institute estimates that at least 21,000 new cases of ovarian cancer will be diagnosed in the U.S. in 2010, and nearly 14,000 women will die of the disease, making it the deadliest of the female reproductive caCancer Institute estimates that at least 21,000 new cases of ovarian cancer will be diagnosed in the U.S. in 2010, and nearly 14,000 women will die of the disease, making it the deadliest of the female reproductive cacancer will be diagnosed in the U.S. in 2010, and nearly 14,000 women will die of the disease, making it the deadliest of the female reproductive cancers.

Martin Matzuk, an endocrinologist at Baylor College of Medicine in Houston, began studying FSH for another reason: to investigate the hormone's role in ovarian cancer.

Another study, conducted by Barbara Weber and her colleagues at the University of Pennsylvania, screened 263 breast cancer patients for BRCA1 mutations and asked them about their family history of breast and ovarian cancers.

Razqallah Hakem, a cancer biologist at the University of Toronto in Ontario, and his colleagues normally study a tumor suppressor called BRCA1, variants of which put women at high risk of breast and ovarian cancer.

Funding for the study was provided by the National Institutes of Health (P50 CA083638, R21 CA156224, 5P30 CA016520 - 36), the Marcus Foundation, the Ovarian Cancer Immunotherapy Initiative, the Ludwig Institute for Cancer Research at the University of Lausanne, and the Ovacure Foundation.

Asian women at risk for breast and ovarian cancers may not be getting the genetic screening that could save them.

Today, a team of researchers at Cold Spring Harbor Laboratory reports in the journal Genes & Development that they have arrived at «new insights into signaling events that underlie metastasis in ovarian cancer cells,» says Gaofeng Fan, Ph.D., postdoctoral investigator who conducted most of the experiments, in the laboratory of his mentor, CSHL Professor Nicholas K. Tonks.

«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.

Researchers looked at tissue samples from ovarian cancer patients.

Patients seeking information about current ovarian cancer treatments can call the U-M Cancer AnswerLine at 800-865cancer treatments can call the U-M Cancer AnswerLine at 800-865Cancer AnswerLine at 800-865-1125.

«Ovarian cancer is often diagnosed at late stages, so chemotherapy is a key part of treatment.

«What we've discovered will help clinicians to better treat women with ovarian cancer,» says Dr. Ben Tsang, senior scientist at the Ottawa Hospital Research Institute and professor at the University of Ottawa.

And that's when ovarian cancer becomes deadly,» says study author J. Rebecca Liu, M.D., associate professor of obstetrics and gynecology at the University of Michigan.

The team's recent study in mice has found that the treatment reduced the mass of ovarian cancer tumors and was more effective at suppressing tumor growth than chemotherapy.

«We know that patients with BRCA mutations are at high risk for developing breast, as well as pancreatic, ovarian, prostate and other cancers, and we have learned over time that BRCA plays a very important role in DNA damage repair.

Women with a family history of two or more immediate family members (mother, sister, daughter) with breast or ovarian cancer or with a positive genetic test for mutations in the BRCA1 or BRCA2 genes may be advised to consider having both breasts removed, because they are at high risk of a new cancer developing in the other breast.

Doctors at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix reported today in Lancet Oncology that a new treatment for ovarian cancer can improve response rates (increase the rate of tumor shrinkage) and prolong the time until cancers Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix reported today in Lancet Oncology that a new treatment for ovarian cancer can improve response rates (increase the rate of tumor shrinkage) and prolong the time until cancers cancer can improve response rates (increase the rate of tumor shrinkage) and prolong the time until cancers recur.

Researchers using data collected by the Ovarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DieOvarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DiegCancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Dieovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Diegcancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DiegCancer Research Annual Meeting in San Diego, CA.

A Mayo Clinic research team has found evidence suggesting that the controversial practice of ovary removal in premenopausal women to prevent ovarian cancer should be discontinued in women who are not at high risk of cancer.

The lab of co-author Dr. Robert Bast Jr., an expert in ovarian cancer and vice president for translational research at MD Anderson, inserted gel - bound carbon nanotubes into the ovaries of rodents to mimic the accumulations that are expected for nanotubes linked to special antibodies that recognize tumor cells.

«By combining my laboratory's expertise in ovarian cancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Meovarian cancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Medcancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Meovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Medcancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of MeOvarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of MedCancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of MedCancer Center at Case Western Reserve University School of Medicine.